More on HROW

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-291.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/10/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Harrow Health (NQ:HROW)
Delayed: 41.43 +1.91 (4.83%)
Prev. Close $39.52  
Open$39.95 
52 Wk High$ 
52 Wk Low$ 
Day High$42.30 
Day Low$39.67 
P/E N/A  
EPS$ 
Volume317,286 


Aug 17, 2026 05:48 PM Form 4 HARROW, INC. For: Aug 14 Filed by: Shojaei Amir
Aug 10, 2026 04:44 PM Harrow Health (HROW) Misses Q2 EPS by 35c
Aug 10, 2026 04:28 PM Form 10-Q HARROW, INC. For: Jun 30
Aug 10, 2026 04:12 PM Form 8-K HARROW, INC. For: Aug 10
Aug 10, 2026 04:05 PM Harrow Announces Second Quarter 2026 Financial Results
Aug 6, 2026 07:15 AM Form 8-K HARROW, INC. For: Aug 03
Aug 6, 2026 07:00 AM Harrow to acquire Tyrvaya nasal spray for dry eye in $100M deal
Aug 6, 2026 07:00 AM Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease
Aug 3, 2026 05:23 AM William Blair Updates Analyst Conviction List For August 2026
Jul 31, 2026 04:06 PM Form SCHEDULE 13G/A HARROW, INC. Filed by: Opaleye Management Inc.
View All Articles

Entities mentioned with HROW

View All Entities